omniture
序祯达生物科技

Latest News

Sequanta selects Olink® Explore 3072 to analyze new cohort study in China

SHANGHAI, Jan. 25, 2022 /PRNewswire/ -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that ...

2022-01-25 19:36 1372

Sequanta and Mission Bio announce strategic partnership

SHANGHAI, July 8, 2021 /PRNewswire/ -- Sequanta Technologies Co., Ltd. ("Sequanta") and Mission Bio...

2021-07-09 15:44 1807